TRCT
ZURA icon

Tower Research Capital (TRC)’s Zura Bio ZURA Stock Holding History

Tower Research Capital (TRC)’s Portfolio ZURA Stock Details ZURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-8,280
Closed -$43.4K – 5637
2025
Q4 		$43.4K Buy
8,280
+8,094
+4,352% +$32K ﹤0.01% 2529
2025
Q3 		$805 Sell
186
-21,843
-99% -$39.3K ﹤0.01% 4938
2025
Q2 		$23.1K Buy
22,029
+14,181
+181% +$17K ﹤0.01% 3595
2025
Q1 		$10.1K Buy
7,848
+4,134
+111% +$6.52K ﹤0.01% 3674
2024
Q4 		$9.29K Buy
3,714
+560
+18% +$2K ﹤0.01% 3918
2024
Q3 		$12.8K Sell
3,154
-4,067
-56% -$15.2K ﹤0.01% 3562
2024
Q2 		$25.3K Buy
7,221
+2,914
+68% +$11.9K ﹤0.01% 3612
2024
Q1 		$11.1K Buy
4,307
+1,584
+58% +$5.61K ﹤0.01% 3607
2023
Q4 		$12.7K Buy
2,723
+965
+55% +$4.82K ﹤0.01% 4025
2023
Q3 		$11.6K Buy
1,758
+486
+38% +$3.25K ﹤0.01% 3973
2023
Q2 		$10.4K Buy
1,272
+1,172
+1,172% +$9.41K ﹤0.01% 4122
2023
Q1 		$1K Buy
+100
New +$1.22K ﹤0.01% 5636

Other funds holding ZURA

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return

Tower Research Capital (TRC)'s ZURA Position: Q1 2026 in Review

Tower Research Capital (TRC) sold out of Zura Bio (ZURA) in Q1 2026, closing a stake of 8,280 shares — an estimated $43.4K sold.

Tower Research Capital (TRC) first reported a position in ZURA in Q1 2023 and held it in 12 quarters. The position peaked at $43.4K in Q4 2025. 94 funds tracked by Wall St. Rank hold ZURA as of Q1 2026.

  • Tower Research Capital (TRC) reported no remaining Zura Bio position as of Q1 2026 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 8,280 Zura Bio shares in Q1 2026, an estimated $43.4K.
  • Tower Research Capital (TRC) first reported a position in Zura Bio in Q1 2023 and held it in 12 quarters.
  • Tower Research Capital (TRC)'s Zura Bio position peaked at $43.4K in Q4 2025.
  • 94 funds tracked by Wall St. Rank held Zura Bio as of Q1 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2026, filed 15 May 2026.